These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Enhancing immune responses against HIV-1 DNA vaccine by coinoculating IL-6 expression vector. Jiang W, Jin N, Cui S, Li Z, Zhang L, Wang H, Han W. J Virol Methods; 2006 Sep; 136(1-2):1-7. PubMed ID: 16793146 [Abstract] [Full Text] [Related]
23. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII. Ramanathan MP, Kutzler MA, Kuo YC, Yan J, Liu H, Shah V, Bawa A, Selling B, Sardesai NY, Kim JJ, Weiner DB. Vaccine; 2009 Jul 09; 27(32):4370-80. PubMed ID: 19497647 [Abstract] [Full Text] [Related]
26. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha. Jiang W, Ren L, Jin N. J Virol Methods; 2007 Dec 09; 146(1-2):266-73. PubMed ID: 17868910 [Abstract] [Full Text] [Related]
27. DNA vaccines for HIV/AIDS. Ulmer JB, Wahren B, Liu MA. Curr Opin HIV AIDS; 2006 Jul 09; 1(4):309-13. PubMed ID: 19372826 [Abstract] [Full Text] [Related]
31. From plasmids to protection: a review of DNA vaccines against infectious diseases. Laddy DJ, Weiner DB. Int Rev Immunol; 2006 Jul 09; 25(3-4):99-123. PubMed ID: 16818367 [Abstract] [Full Text] [Related]
32. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria. Rainczuk A, Scorza T, Spithill TW, Smooker PM. Infect Immun; 2004 Oct 09; 72(10):5565-73. PubMed ID: 15385453 [Abstract] [Full Text] [Related]
33. Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I. Cuesta AM, Suárez E, Larsen M, Jensen KB, Sanz L, Compte M, Kristensen P, Alvarez-Vallina L. Immunology; 2006 Apr 09; 117(4):502-6. PubMed ID: 16556264 [Abstract] [Full Text] [Related]
34. DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. Bellier B, Dalba C, Clerc B, Desjardins D, Drury R, Cosset FL, Collins M, Klatzmann D. Vaccine; 2006 Mar 24; 24(14):2643-55. PubMed ID: 16481074 [Abstract] [Full Text] [Related]
35. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope. Lu Y, Ouyang K, Fang J, Zhang H, Wu G, Ma Y, Zhang Y, Hu X, Jin L, Cao R, Fan H, Li T, Liu J. Vaccine; 2009 Aug 27; 27(39):5411-8. PubMed ID: 19616501 [Abstract] [Full Text] [Related]
37. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F, Rodríguez JR, Garzón A, Rodríguez D, Esteban M. Virus Res; 2006 Mar 27; 116(1-2):11-20. PubMed ID: 16214252 [Abstract] [Full Text] [Related]
39. Construction, expression and immunoassay detection of recombinant plasmid encoding fusion protein of Roman chicken complement C3d and Newcastle disease virus F gene. Liu D, Niu ZX. Scand J Immunol; 2008 Dec 27; 68(6):598-606. PubMed ID: 19055698 [Abstract] [Full Text] [Related]
40. DNA vaccines against enteric infections. Herrmann JE. Vaccine; 2006 May 01; 24(18):3705-8. PubMed ID: 16095769 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]